Debt-to-equity of Anixa Biosciences Inc from 30 Apr 2015 to 31 Oct 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Anixa Biosciences Inc quarterly Debt-to-equity in % history and change rate from 30 Apr 2015 to 31 Oct 2025.
  • Anixa Biosciences Inc Debt-to-equity for the quarter ending 31 Oct 2025 was 13%, a 40% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 13% +3.7% +40% 31 Oct 2025
Q2 2025 13% +4.7% +56% 31 Jul 2025
Q1 2025 12% +4.3% +55% 30 Apr 2025
Q4 2024 11% +3.2% +42% 31 Jan 2025
Q3 2024 9.4% +2.5% +36% 31 Oct 2024
Q2 2024 8.4% +1.7% +26% 31 Jul 2024
Q1 2024 7.8% +1.8% +30% 30 Apr 2024
Q4 2023 7.5% +2% +36% 31 Jan 2024
Q3 2023 6.9% +1.2% +21% 31 Oct 2023
Q2 2023 6.7% +1.8% +36% 31 Jul 2023
Q1 2023 6% 30 Apr 2023
Q4 2022 5.5% 31 Jan 2023
Q3 2022 5.7% 31 Oct 2022
Q2 2022 4.9% 31 Jul 2022
Q3 2020 17% 31 Oct 2020
Q2 2020 20% 31 Jul 2020
Q3 2017 118% -96% -45% 31 Oct 2017
Q2 2017 308% +165% +114% 31 Jul 2017
Q1 2017 846% +739% +696% 30 Apr 2017
Q4 2016 1515% +1433% +1746% 31 Jan 2017
Q3 2016 214% +147% +217% 31 Oct 2016
Q2 2016 144% +71% +97% 31 Jul 2016
Q1 2016 106% -35% -25% 30 Apr 2016
Q4 2015 82% 31 Jan 2016
Q3 2015 67% 31 Oct 2015
Q2 2015 73% 31 Jul 2015
Q1 2015 141% 30 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.